Grants and Contributions

The specific objective of this funding opportunity is to recognize exemplary completed work and build capacity in the six (6) cross-cutting research pools of a healthy research ecosystem in keeping with both the CIHR Strategic Plan 2021-31 and the CIHR-IMHA Strategic Plan 2021-26.

The specific objective of this funding opportunity is to recognize exemplary completed work and build capacity in the six (6) cross-cutting research pools of a healthy research ecosystem in keeping with both the CIHR Strategic Plan 2021-31 and the CIHR-IMHA Strategic Plan 2021-26.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The specific objectives of this funding opportunity are to:

• Support original, high quality research in digital health that has the potential to generate pilot data for future research (e.g. Project Grant and funding at other Agencies/Councils), including research into evaluation, scale up, or implementation of a digital health product, platform or application.
• Incentivize research that focuses on digital health solutions for the CIHR-IMHA mandate areas.
• Foster a community of CIHR-IMHA digital health researchers that partner with Canadian leaders in equitable digital science.
• Provide research leadership, stimulate innovative research and practice, and strengthen research capacity by dedicating funds to early and mid-career researchers as part of CIHR-IMHA’s commitment to Nurture Leaders.
• Strengthen health research through the incorporation of patient and/or community engagement.

The project is meant to allow Stoked Bio to hire a much needed associate-level, new graduate in the position of Corporate Development. In this role, the associate will be responsible for supporting strategic growth initiatives and partnership activities for the early-stage biotech drug discovery company. Conduct market research, financial modeling, and competitive analysis to evaluate opportunities. Conduct industry-wide company reviews to drive business development efforts and support executive decision-making.

Development of the preliminary engineering for shipyards to construct a 24m battery-electric ferry to serve short-haul routes, starting with Amherstburg–Boblo Island.

The project will support pilot testing of AI strategies, determine target architecture and quantitative technical objectives for implementation of an AI solution. Specifically, this AI solution will leverage gait data from the WithinStride™ system, combined with publicly available human movement datasets, to explore the feasibility of predicting knee joint loading and force sensing—key biomechanical parameters for musculoskeletal health. This pilot will validate AI architectures and inform the business case for future implementation in clinical and research markets.

360 Energy Inc. is developing Envy, an AI-powered energy intelligence engine that powers their Envirally platform, designed to help organizations optimize energy consumption, reduce their carbon footprint, and lower costs to improve sustainability. This cloud-based platform delivers enhanced AI capabilities while automating data acquisition and providing actionable insights, empowering organizations to easily manage and improve their energy performance. Ultimately, Envy contributes to a more sustainable future by enabling data-driven decisions about energy usage and driving positive environmental impact.

A detailed and in depth economic feasibility study and pilot experiment for renewable energy waste recycling identifying, exploring, and summarizing domestic and international factors to support the business case of SUNSET Renewable Asset Management Inc.

The current project advances the manufacturing readiness of Allarta’s Microgel Technology using scale-up engineering methodologies. Additionally, Allarta is extending the market penetration potential of its cell encapsulation devices through cold-chain solutions, allowing for the scale-up and commercial application of cell therapies beyond life-threatening illnesses which can bear the burden of ‘just-in-time’ production logistics.